Bladder cancer trials in Hong Kong

In Hong Kong 10 Also abroad 626

10 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Performance, Feasibility, and Safety Study for a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours: First-In-Human Trial
Where
Shatin
Age
18 years to 75 years
People
10
Run by
Chinese University of Hong Kong
See details and how to joinNCT06281080
Phase 3Taking people
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Where
Hong Kong
Age
18 years and over
People
641 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06319820
No phaseNot yet taking people in Hong Kong
The Role of ERBT Plus Adjuvant Intravesical Induction and Maintenance Chemotherapy for Intermediate-Risk NMIBC
Where
Hong Kong, Shatin
Age
18 years and over
People
440
Run by
Chinese University of Hong Kong
See details and how to joinNCT07907575
No phaseNot yet taking people in Hong Kong
Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer
Where
Hong Kong
Age
18 years and over
People
60
Run by
Chinese University of Hong Kong
See details and how to joinNCT07095751
No phaseTaking people
The Global En Bloc Resection of Bladder Tumour Registry
Where
Hong Kong
Age
18 years and over
People
5,000
Run by
Chinese University of Hong Kong
See details and how to joinNCT04934540
No phaseTaking people
Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial Carcinoma
Where
Hong Kong
Age
18 years and over
People
10
Run by
Chinese University of Hong Kong
See details and how to joinNCT07557563
No phaseTaking people
Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC
Where
Hong Kong, Sheung Shui
Age
18 years and over
People
732
Run by
Chinese University of Hong Kong
See details and how to joinNCT07724886
Phase 1/2Taking people
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Where
Hong Kong
Age
18 years and over
People
180 worldwide
Run by
Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00
No phaseEnrolling by invitation
Virtuoso Improving Anatomic Bladder Lesion Excision (VIABLE) Trial
Where
Hong Kong
Age
22 years and over
People
30
Run by
Virtuoso Surgical, Inc.
See details and how to joinNCT06940648
Phase 1Taking people
Ambulatory Flexible URS for UTUC Surveillance
Where
Hong Kong
Age
18 years and over
People
10
Run by
Chinese University of Hong Kong
See details and how to joinNCT06848868